Report Says New Treatments Have Dramatically Improved Outcomes for People with Peritoneal Mesothelioma, According to Surviving Mesothelioma

Share Article

Researchers say recent improvements in treatments for peritoneal mesothelioma have more than doubled life expectancy for patients.

Peritoneal Mesothelioma Survival

New Treatments Improve Mesothelioma Survival

The advent of cytoreduction (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has dramatically improved survival outcomes...

A team of doctors in Virginia say the outlook for people with peritoneal mesothelioma is better than ever thanks to ongoing improvements in treatment approach. Surviving Mesothelioma has the full article on its website. Click here to read it now.

Scientists with Virginia Commonwealth University and the Massey Cancer Center analyzed the average survival of people with peritoneal mesothelioma, a rare type of mesothelioma that occurs in the abdominal lining. Many patients who, in past years, would not have been expected to live beyond a year, are now living two to four times that long.

“The advent of cytoreduction (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has dramatically improved survival outcomes with wide median survival estimates between 2.5 to 9 years,” writes lead author Ali Raza, MD.

The study, published in the Journal of Gastroenterology, says more evenly-matched studies are needed to get a more specific idea of the difference new treatments have made.

“Even though the survival times vary widely between peritoneal mesothelioma studies, they are all consistently finding a big improvement with CRS/HIPEC,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “That is great news for people fighting this rare form of mesothelioma.”

The new report also touches on an even newer treatment for peritoneal mesothelioma, based on a novel molecular target. Read all the details in New Treatments Have Improved Outcomes for Peritoneal Mesothelioma, now available on the Surviving Mesothelioma website.

Raza, A et al, “Advanced in the management of peritoneal mesothelioma”, September 7, 2014, World Journal of Gastroenterology, pp. 11700-11712, http://www.ncbi.nlm.nih.gov/pubmed/25206274

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website